Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 21, 2018

Study Completion Date

December 31, 2018

Conditions
Lower Urinary Tract Symptoms
Interventions
DRUG

Lactobacillus

Eligible patients will undergo 1 Lactobacillus pediatric dose (Culturelle GG 10 Billion live organisms) instillation by study personnel at the study site. For the intravesicular Lactobacillus instillation, the contents of 1 Lactobacillus capsule will be mixed into sterile 0.9% saline using an age-based estimate of bladder capacity. Similar to adults, this bladder instillation will represent 10% of the estimated maximum bladder volume based on age.

Trial Locations (2)

20010

Children's National Medical Center, Washington D.C.

MedStar National Rehabilitation Hospital, Washington D.C.

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Children's National Research Institute

OTHER

collaborator

Georgetown University

OTHER

lead

Medstar Health Research Institute

OTHER